Supplemental Tables and Figures from Comparison of Biomarker Assays for EGFR: Implications for Precision Medicine in Patients with Glioblastoma
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table S2. Concordance of FISH and WES results. Supplementary Table S3. Point mutations identified in EGFR. Supplementary Table S4. Concordance of FISH and RT-PCR results. Supplementary Table S5. Concordance of FISH and RNAseq results. Supplementary Table S6. Concordance of FISH and IHC results. Supplementary Figure S1. Venn diagram showing overlap among EGFR assays in 206 GBMs. Supplementary Figure S2. FISH for EGFR amplification in GBM. Supplementary Figure S3. EGFR polysomy is not associated with increased EGFR expression. Supplementary Figure S4. Point mutations identified in the EGFR gene in patient samples. Supplementary Figure S5. EGFR amplification and mRNA expression are strongly associated.
Authors: Andrew B. Lassman, Lisa Roberts-Rapp, Irina Sokolova, Minghao Song, Ekaterina Pestova, Rupinder Kular, Carolyn Mullen, Zheng Zha, Xin Lu, Erica Gomez, Anahita Bhathena, David Maag, Priya Kumthekar, Hui K. Gan, Andrew M. Scott, Maria Guseva, Kyle D. Holen, Peter J. Ansell, Martin J. van den Bent
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361933150